fired

Lots of us affected, the vast majority being Scarlet. The division is all but gone. About 33 phlebotomists remain nationwide - originally we had about 250 nationwide. I bet we'd be in a stronger position if we didn't have a 10 million dollar lawsuit to pay.

Check this out from Seeking Alpha: https://www.google.com/amp/s/seekingalpha.com/amp/article/4133495-2-small-biopharma-ceos-sacked "I refer, of course, to Egalet (EGLT). It is hard to imagine a company that has done a better job of destroying shareholder value here in 2017 as the chart below...